Basic Cardiovascular Sciences  /  GS02. Heart Failure and Cardiomyopathy  /  Hydrogen Sulfide and HFpEF
Logo

American Heart Association

  43
  0

Final ID:

Hydrogen Sulfide and HFpEF

  • Lefer, David  ( Cedars-Sinai Medical Center , Los Angeles , California , United States )
    • Author Disclosures:
    David Lefer: DO have relevant financial relationships ; Consultant:Gordian Biotechnology:Active (exists now) ; Consultant:Sulfagenix, Inc.:Active (exists now)
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

GS02. Heart Failure and Cardiomyopathy

Monday, 07/22/2024 , 03:15PM - 04:30PM

General Session

More abstracts on this topic:
MYZAP, m6 methylation and Cardiomyopathy

Accornero Federica

Cardiac Macrophage are Key Immune Drivers of Cardiometabolic HFpEF

Goel Mehak, Prabhu Sumanth, Ismahil Ameen, Sonkar Ravi, Bansal Shyam, Zhu Yujie, Liu Wei, Hamid Tariq, Rokosh Gregg, Katsnelson Michael

More abstracts from these authors:
Aberrant Trans- and De- Nitrosylation Underpins Nitrosative Stress in Cardiometabolic HFpEF

Li Zhen, Borch Jensen Martin, Vondriska Thomas, Lefer David, Gehred Natalie, Gromova Tatiana, Lapenna Kyle, Sharp Thomas, Chen Jingshu, Shambhu Smitha, Yu Xiaoman, Goodchild Traci

3-Mercaptopyruvate Sulfurtransferase is a Critical Regulator of Branched-Chain Amino Acid Catabolism in Cardiometabolic HFpEF

Li Zhen, Doiron Jake, Xia Huijing, Lapenna Kyle, Sharp Thomas, Yu Xiaoman, Nagahara Noriyuki, Goodchild Traci, Lefer David

You have to be authorized to contact abstract author. Please, Login
Not Available